Seurat Therapeutics Announces Novel Mechanisms from Rat Migraine Model of Intranasal Insulin-like Growth Factor-1 (IMAGE)

Polsky Center for Entrepreneurship and Innovation

Seurat Therapeutics Announces Novel Mechanisms from Rat Migraine Model of Intranasal Insulin-like Growth Factor-1

Caption

Intranasal IGF-1 inhibits trigeminal system activation caused by spreading depression, and reduced levels of calcitonin gene-related peptide, as well as other trigeminal pathway biomarkers.

Credit

Graphical article summary from Won L and Kraig RP, Brain Research, 2020

Usage Restrictions

Image may be used with appropriate credit.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.